CashuAstraZeneca's Tozorakimab Shows Promise in Chronic Obstructive Pulmonary Disease Treatment3 days ago
CashuHealthcare Economics Shift: Focus on Prescription Drug Affordability and Patient Access Initiatives14 days ago
CashuAstraZeneca Expands Discounted Medications to 54, Enhancing Accessibility and Affordability for Patients15 days ago
benzinga.comAstraZeneca Scores Pediatric Win While Adult Trial Falls Short In Rare Bone Disease2 days ago
cnbc.comAstraZeneca stock jumps 4% after surprise trial win for lung disease drug where rivals have failed6 days ago
cnbc.comStocks making the biggest moves premarket: AstraZeneca, Unity Software, Coinbase & more6 days ago
benzinga.comAbivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears9 days ago
benzinga.comMark Cuban Refuses To 'Rip On' TrumpRx, Lauds It For Saving 'A Lot Of ' Patients' Money14 days ago
benzinga.comAmgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report17 days ago